These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

Beyond antiresorptive medications, anabolic bone-building medications, including teriparatide, abaloparatide (Tymlos), and ...

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

Fracture risk and treatment need careful individual assessment Osteopenia is the most common result of a bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) in older ...

Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Bosaya is approved to treat postmenopausal women with osteoporosis at high risk for fracture ...

Novartis Cosentyx meets primary and all secondary endpoints in phase III trial in patients with polymyalgia rheumatica: Basel Thursday, October 23, 2025, 09:00 Hrs [IST] Novartis ...

Agne Pasko joined Alvotech in 2019, and has held several senior roles in Commercial Operations, Supply Chain and Business Development, driving revenue growth, new partnerships and portfolio expansion.

Concerned about bone loss with ageing Incorporating black raisins into your diet can help to fortify bones naturally while ...

FDA-approved indications for hormone therapy include moderate to severe VMS, prevention of osteoporosis, and management of premature menopause or early estrogen deficiency. Indirect benefits may ...

Dr. H. Kurtis Biggs explores the future of orthopedic innovation, including advancements in robotics, AI, and imaging and why ...

First-time presentation examining bone outcomes in early postmenopausal women ...

Bone regeneration is the natural process by which new bone is formed to repair or replace damaged or lost bone tissue. This biological process involves the activation of osteogenic cells ...